Immunotherapy with wasp venom is accompanied by wide-ranging immune responses that need further exploration.

@article{Brasch2009ImmunotherapyWW,
  title={Immunotherapy with wasp venom is accompanied by wide-ranging immune responses that need further exploration.},
  author={Jochen Brasch and Tzanka Maidusch},
  journal={Acta dermato-venereologica},
  year={2009},
  volume={89 5},
  pages={
          466-9
        }
}
Immunotherapy with wasp allergen leads to a variety of specific immunological changes. It is unknown, however, whether unspecific effects also occur, and which parameter shifts might indicate treatment success. Therefore, data of patients who had completed immunotherapy with wasp venom were analysed retrospectively for a change in the following parameters after therapy: threshold of skin tests with wasp venom, total and specific serum IgE, specific serum IgG and IgG4, and binding of IgE and… 

Figures from this paper

Allergen-specific immunotherapy of Hymenoptera venom allergy – also a matter of diagnosis

During the last decade the detailed knowledge of the allergen composition of hymenoptera venoms has substantially improved diagnosis and therapy of venom allergy, as well as on novel directions trying to improve therapy.

From Molecular Cloning to Vaccine Development for Allergic Diseases

Basic aspects and experimental and clinical results of this process are presented and a broad and important activity to offer in the near future preparations with enhanced clinical efficacy and safety are noted.

Congruence of the current practices in Hymenoptera venom allergic patients in Poland with EAACI guidelines

Comparision between Poland and the United Kingdom revealed that health service organization and health care funding may play a major role in the provision of allergy services, indicating areas requiring better compliance with EAACI guidelines.

How effective is oral immunotherapy for food allergies and can it already be applied in clinic

The results are supported only by a limited amount of studies and the general conclusions are debatable because there is much variation between studies in protocols (duration of therapy, dose increase scheme, way to establish allergies) and characteristics of patients enrolled in the trails (mean age, multiple food allergies, severity of allergy).

References

SHOWING 1-10 OF 17 REFERENCES

Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.

During successful VIT there are changes in intensity and number of IgE and IgG4 binding bands, which could reflect the immunological improvement induced by VIT.

[Venom immunotherapy. Side effects and efficacy of treatment].

  • F. RuëffB. Przybilla
  • Medicine
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  • 2008
VIT according to rush schedules in inpatients remains indispensable, and patients with significant risk factors may be treated from the beginning with an elevated maintenance dose, particularly when they are allergic to honeybee venom.

Advances in hymenoptera venom immunotherapy

This overview examines advances in various aspects of venom immunotherapy, capable of improving health-related quality of life and much remains to be accomplished.

Rapid venom immunotherapy update

There is evidence that pretreatment with antihistamines before venom injections during rapid venom immunotherapy may reduce the numbers and severity of injection-related systemic reactions, as well as improve long-term outcomes in preventing subsequent resting systemic reactions in the field.

[Specific immunotherapy (SIT) in atopic dermatitis and food allergy].

Double-blind, placebo-controlled clinical studies are now available showing good efficacy of SIT in patients with AD, and clues from case reports and small clinical studies suggesting effectiveness of S IT both for food allergies and associated aeroallergens.

Total and specific serum IgE decreases with age in patients with allergic rhinitis, asthma and insect allergy but not in patients with atopic dermatitis

Total and specific serum IgE was significantly decreased as a function of age in patients with allergic rhinitis and asthma and with insect allergy, andImmunosenescence does not affect increased IgE levels in atopic patients with AD and/or high serum Ig E levels indicating that in these subgroups of patients the atopic propensity remains into advanced age.

Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice

Based on the knowledge of the living conditions and habitat of social Aculeatae a series of recommendations have been formulated which can potentially greatly minimize the risk of field re‐sting, including epinephrine auto‐injectors.

Long-term efficacy of venom immunotherapy.

  • T. HafnerL. DubuskeM. Košnik
  • Medicine, Psychology
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2008

Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy

Sublingual immunotherapy for allergic rhinitis: systematic review and metaanalysis, from proven prevention to putative rapid relief of allergic symptoms, and an analysis of published studies.